GROUPEMENT DES LABORATOIRES FRANCAIS/SORAS – Trademark Portfolio

Entity Type: 99

GROUPEMENT DES LABORATOIRES FRANCAIS/SORAS holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 9 filings in this category. Currently, 5 trademarks are registered. Notable registered marks include E, FILADERME, ROSAMELIS, EMBRYODERME, and EMBRYOLISSE.

16 rue Danton

F-92130 ISSY-LES -MOULINEAUX

9 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

GROUPEMENT DES LABORATOIRES FRANCAIS/SORAS's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

3
Cosmetics & Cleaning (9 filings)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

Frequently Asked Questions

How many trademarks does GROUPEMENT DES LABORATOIRES FRANCAIS/SORAS have?

GROUPEMENT DES LABORATOIRES FRANCAIS/SORAS has 9 U.S. trademarks filed with the USPTO. Of these, 5 registered, 4 abandoned.

What trademark classes does GROUPEMENT DES LABORATOIRES FRANCAIS/SORAS file in?

GROUPEMENT DES LABORATOIRES FRANCAIS/SORAS files trademarks across 1 Nice Classification class. The most active classes are Class 3 (Cosmetics & Cleaning). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.

What are GROUPEMENT DES LABORATOIRES FRANCAIS/SORAS's most well-known trademarks?

GROUPEMENT DES LABORATOIRES FRANCAIS/SORAS's registered trademark portfolio includes well-known marks such as E, FILADERME, ROSAMELIS, EMBRYODERME, and EMBRYOLISSE. These are among 5 currently registered trademarks in the portfolio.

What is GROUPEMENT DES LABORATOIRES FRANCAIS/SORAS's trademark registration success rate?

GROUPEMENT DES LABORATOIRES FRANCAIS/SORAS has a 56% trademark registration rate, with 5 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.